Dermatologic infections in cancer patients treated with EGFRI therapy

Patients who experience dermatologic toxic effects from epidermal growth factor receptor inhibitors (EGFRIs) have a high prevalence of skin and nail infections, according to a new study published online December 9 in the Journal of the National Cancer Institute.

Read the whole article on Physorg

More from Physorg